NCT00040560View on ClinicalTrials.gov

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

PHASE1UnknownINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Lung NeoplasmsCarcinoma, Non-Small-Cell LungBrain NeoplasmsMetastases, Neoplasm
Interventions
DRUG

111In-DAC

PROCEDURE

Diagnostic

Trial Locations (2)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

95661

Sutter Roseville Medical Center, Roseville

Sponsors

Lead Sponsor

Copharos
All Listed Sponsors
lead

Copharos

INDUSTRY